DSGN

Design Therapeutics, Inc.

• NASDAQ·23h ago

  AZN, Daiichi's Datroway Wins FDA Nod for Expanded Use in Breast Cancer

• Benzinga·6d ago

  TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday

• TipRanks·6d ago

  Analysts Conflicted on These Healthcare Names: Design Therapeutics (DSGN), Pro Medicus Limited (OtherPMCUF) and Boston Scientific (BSX)

• NASDAQ·6d ago

  Notable Tuesday Option Activity: AEVA, RKLB, DSGN

• TipRanks·05/19 13:20

  Analysts’ Top Healthcare Picks: Neuren Pharmaceuticals Limited (NURPF), Design Therapeutics (DSGN)

• Dow Jones·05/18 18:33

  Design Therapeutics Down Over 25%, on Track for Largest Percent Decrease Since August 2023 -- Data Talk

• Benzinga·05/18 18:26

  Design Therapeutics Stock Wobbles After Rare Genetic Disease Data

• Benzinga·05/18 18:25

  Crude Oil Gains Over 2%; US Homebuilder Sentiment Increases In May

• Reuters·05/18 17:44

  BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, BlackRock TCP Capital, Boston Scientific

• Benzinga·05/18 16:18

  Nasdaq Down 200 Points; Brady Earnings Top Views

• TipRanks·05/18 16:08

  Midday Fly By: Dominion to combine with NextEra, Publicis to acquire LiveRamp

• Reuters·05/18 15:38

  BUZZ-Design Therapeutics falls after early-stage data for genetic disorder treatment

• Reuters·05/18 14:32

  DESIGN THERAPEUTICS INC <DSGN.O>: RBC RAISES TARGET PRICE TO $20 FROM $14

• Dow Jones·05/18 12:24

  Design Therapeutics Shares Rise on Positive Friedreich Ataxia Study Data

• NASDAQ·05/18 12:07

  Design Therapeutics Posts Four-Week RESTORE-FA Gains In Friedreich Ataxia; Stock Up